当前位置:首页 - 行情中心 - 我武生物(300357) - 财务分析 - 现金流量表

我武生物

(300357)

  

流通市值:169.91亿  总市值:183.78亿
流通股本:4.84亿   总股本:5.24亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金850,177,687.74516,650,905.38253,680,603.8890,740,667.96
  收到的税费返还---13,716
  收到其他与经营活动有关的现金20,446,041.7412,510,748.277,966,416.8323,776,899.09
  经营活动现金流入小计870,623,729.48529,161,653.65261,647,020.63914,531,283.05
  购买商品、接受劳务支付的现金22,371,170.5116,271,293.878,840,894.8228,308,352.87
  支付给职工以及为职工支付的现金214,559,678.61142,754,196.2672,812,019.48283,537,448.19
  支付的各项税费57,379,994.6548,447,199.2324,605,269.0698,353,193.44
  支付其他与经营活动有关的现金289,421,808.2121,173,112.1969,505,168.62241,892,283.33
  经营活动现金流出小计583,732,651.97328,645,801.55175,763,351.98652,091,277.83
  经营活动产生的现金流量净额286,891,077.51200,515,852.185,883,668.65262,440,005.22
二、投资活动产生的现金流量:
  收回投资收到的现金741,491,647.25451,567,200351,000,000204,000,000
  取得投资收益收到的现金3,205,479.621,465,742.81992,400.122,905,526.68
  处置固定资产、无形资产和其他长期资产收回的现金净额---15,000
  收到的其他与投资活动有关的现金---9,638,557.17
  投资活动现金流入小计744,697,126.87453,032,942.81351,992,400.12216,559,083.85
  购建固定资产、无形资产和其他长期资产支付的现金110,988,794.9688,217,827.0245,487,365.26117,970,037.91
  投资支付的现金752,760,000489,760,000285,760,000682,838,000
  支付其他与投资活动有关的现金31,204,529.999,155,282.028,159,851.3211,346,201.5
  投资活动现金流出小计894,953,324.95587,133,109.04339,407,216.58812,154,239.41
  投资活动产生的现金流量净额-150,256,198.08-134,100,166.2312,585,183.54-595,595,155.56
三、筹资活动产生的现金流量:
  吸收投资收到的现金---13,077
  其中:子公司吸收少数股东投资收到的现金---13,077
  取得借款收到的现金20,000,00015,000,00015,000,0002,762,114.33
  筹资活动现金流入小计20,000,00015,000,00015,000,0002,775,191.33
  偿还债务支付的现金27,628,987.8522,577,392.7122,577,392.7144,121,654.39
  分配股利、利润或偿付利息支付的现金115,179,627.1652,430,858.3452,430,858.3497,447,671.33
  支付其他与筹资活动有关的现金5,009,063.523,474,035.31,458,104.677,785,789.07
  筹资活动现金流出小计147,817,678.5378,482,286.3576,466,355.72149,355,114.79
  筹资活动产生的现金流量净额-127,817,678.53-63,482,286.35-61,466,355.72-146,579,923.46
四、汇率变动对现金及现金等价物的影响-4,046.21-4,641.7-1,126.247,802.61
五、现金及现金等价物净增加额8,813,154.692,928,757.8237,001,370.23-479,727,271.19
  加:期初现金及现金等价物余额97,862,286.8197,862,286.8197,862,286.81577,589,558
  期末现金及现金等价物余额106,675,441.5100,791,044.63134,863,657.0497,862,286.81
补充资料:
  净利润-170,429,226.33-304,338,394.93
  资产减值准备-2,207,917.71-958,291.22
  固定资产和投资性房地产折旧-16,183,925.54-30,976,028.13
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-16,183,925.54-30,976,028.13
  无形资产摊销-6,725,077.34-12,609,822.6
  长期待摊费用摊销-1,208,203.77-2,279,811.63
  处置固定资产、无形资产和其他长期资产的损失--630,073.33--568,926.85
  固定资产报废损失-320,072.27-1,415,047.93
  公允价值变动损失--1,328,169.78--2,429,584.92
  财务费用-406,344.87-1,062,798.45
  投资损失--16,143.8--4,040,186.3
  递延所得税--480,927.78--597,032.92
  其中:递延所得税资产减少--452,417.26--566,501.11
    递延所得税负债增加--28,510.52--30,531.81
  存货的减少-1,380,977.75-1,304,079.78
  经营性应收项目的减少-10,543,053.48--99,787,232.1
  经营性应付项目的增加--9,356,634.69-7,691,367.51
  现金的期末余额-100,791,044.63-97,862,286.81
  减:现金的期初余额-97,862,286.81-577,589,558
  现金及现金等价物的净增加额-2,928,757.82--479,727,271.19
公告日期2025-10-242025-08-222025-04-192025-04-19
审计意见(境内)标准无保留意见
TOP↑